Not surprisingly, both shallow (referring to heterozygous) and deep deletions result in enrichment of the RB pathway and decreased expression of RB1 (Figures 1D and S1D), which can be validated in other cancer types from TCGA (Figure S2). Here, RB1 is linked to cancer.